Plain-English translation of NCT07224464 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new treatment called the Sarah Nanotechnology System, which uses tiny iron-based nanoparticles injected into your bloodstream combined with a magnetic field to heat and damage cancer cells. The nanoparticles are designed to collect in tumor tissue, and then a special magnetic machine gently heats those particles to kill the cancer while protecting healthy tissue nearby. The study is checking whether this treatment is safe and finding the best dose and duration for future research.
Advanced cancers that have spread throughout the body often don't respond well to standard treatments like chemotherapy and radiation. This trial is exploring whether a completely new approach—using magnetic heat to target tumors—could offer hope to patients who have run out of other options.
You likely qualify if…
You likely don't qualify if…
You will receive a single intravenous injection of the nanoparticles, followed by placement under a magnetic machine for 12–20 minutes (depending on which dose level you're in), during which the device heats the particles in your tumor. Your vital signs and skin temperature will be monitored continuously throughout, and a cooling blanket will help keep your skin comfortable. The study will follow you for safety monitoring, with the goal of determining the safest and most effective dose for this new treatment approach.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
United States